Blood pressure medication recalled due to possible carcinogen

Posted: Updated:
EDISON -

A company is voluntarily recalling one lot of a blood pressure medication due to trace amounts of an impurity that has been classified as a possible carcinogen, according to the FDA.

American Health Packaging is recalling the following product:

Valsartan Tablets USP 160 mg, 100 count Unit Dose Blisters, Carton NDC#: 60687-139-01, (Individual Dose NDC: 60687-139-11), 179791, Exp. Date: 3/31/2020

The product is used to control high blood pressure and is distributed nationwide.

Patients who are prescribed Valsartan are advised to continue taking the medication until their doctor can prescribe an alternative.

No injuries have been reported.

N-Nitrosodiethylamine, or NDEA, is has been classified as a probable human carcinogen.

For more information, click here.

sorry to interrupt
your first 20 are free
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please enjoy 20 complimentary views of articles, photos, and videos during the next 30 days.
you have reached your 20 view limit
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please login or create an account to continue enjoying News12.
Our sign-up page is undergoing maintenance and is not currently available. However, you will be given direct access to news12.com while we complete our upgrade.
When we are back up and running you will be prompted at that time to complete your sign in. Until then, enjoy the local news, weather, traffic and more that's "as local as local news gets."